<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-158627" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Epidermolysis Bullosa</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khanna</surname>
            <given-names>Divya</given-names>
          </name>
          <aff>University Hospitals Coventry And Warwickshire</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bardhan</surname>
            <given-names>Ajoy</given-names>
          </name>
          <aff>MEMBERSHIP OF ROYAL COLLEGE OF PHYSICIANS</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Divya Khanna declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ajoy Bardhan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-158627.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Epidermolysis bullosa (EB) defines&#x000a0;a prototypic group of rare, inherited dermatoses, characteristically featuring skin fragility secondary to structural&#x000a0;defects in the dermo-epidermal junction. This skin fragility creates an impaired tolerance to mechanical stress. Trivial&#x000a0;mechanical trauma and shear stress can provoke skin blistering, erosions, and ulceration.<xref ref-type="bibr" rid="article-158627.r1">[1]</xref> This places patients with certain forms of&#x000a0;epidermolysis bullosa at a greater risk of infection, disabling deformities secondary to heavy scarring, and&#x000a0;aggressive cutaneous malignancy,&#x000a0;leading to early fatality in some cases. An extensive phenotypic range is described, ranging from fragility and blistering localized to areas of weight-bearing or pressure to widespread generalized involvement, including extracutaneous disease. Thus, certain subtypes of EB confer high morbidity, with a risk of increased mortality due to&#x000a0;multi-system&#x000a0;pathology.<xref ref-type="bibr" rid="article-158627.r2">[2]</xref><xref ref-type="bibr" rid="article-158627.r3">[3]</xref></p>
        <p>Sixteen&#x000a0;genes have been implicated in underpinning at least 30 observed epidermolysis bullosa&#x000a0;subtypes. Each subtype features varying phenotypic severity and impact on morbidity and mortality. These subtypes have been organized into&#x000a0;4 major groups based&#x000a0;on the ultrastructural plane within the&#x000a0;dermo-epidermal junction that the defect impacts:</p>
        <p><bold>Epidermolysis Bullosa Simplex (EBS)&#x000a0;</bold>comprises around 70% of all&#x000a0;epidermolysis bullosa cases and features a fragility defect in the epidermis, mostly inherited in an autosomal dominant pattern.&#x000a0;</p>
        <p><bold>Junctional Epidermolysis Bullosa (JEB)</bold>&#x000a0;is an autosomal recessive fragility defect seen specifically within the lamina lucida and makes up around 5% of all&#x000a0;epidermolysis bullosa cases.</p>
        <p><bold>Dystrophic Epidermolysis Bullosa (DEB)</bold>&#x000a0;represents around 25% of all&#x000a0;epidermolysis bullosa cases and may be autosomal dominant or recessive.&#x000a0;Dystrophic epidermolysis bullosa features a fragility defect below the lamina densa of the basement membrane zone.</p>
        <p><bold>Kindler Epidermolysis Bullosa</bold>&#x000a0;<bold>(KEB)</bold> is the rarest of the&#x000a0;4 major epidermolysis bullosa types inherited in an autosomal recessive pattern. The kindlin-1 protein is affected in Kindler epidermolysis bullosa, resulting in fragility in any plane of the dermo-epidermal junction. Around&#x000a0;400 cases&#x000a0;have been&#x000a0;reported worldwide.<xref ref-type="bibr" rid="article-158627.r4">[4]</xref></p>
        <p>Inherited epidermolysis bullosa is distinct from epidermolysis bullosa aquisita, a separate, non-inherited, immunobullous disorder characterized by antibodies against type VII collagen.<xref ref-type="bibr" rid="article-158627.r1">[1]</xref></p>
      </sec>
      <sec id="article-158627.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>As&#x000a0;epidermolysis bullosa results from defects within the dermo-epidermal junction, it is imperative to appreciate the components of this structure before&#x000a0;understanding pathophysiology.<xref ref-type="bibr" rid="article-158627.r5">[5]</xref></p>
        <p>The epidermis is the uppermost layer of the dermo-epidermal junction and overlies the dermis. The basement membrane zone is found between the lower (basal) layer of the epidermis and the upper (papillary) layer of the dermis. The&#x000a0;basement membrane zone is multifunctional: it anchors the epidermis to the dermis, provides scaffolding for cellular migration and adhesion, forms a selectively permeable membrane for cells and molecules, and serves as a model for the differentiation, development, repair, and replacement of cells. The&#x000a0;basement membrane zone&#x000a0;consists of&#x000a0;2 layers: the lamina lucida, which lies below the basal epidermis, and the lamina densa, which lies below the lamina lucida.&#x000a0;</p>
        <p>The&#x000a0;layers of the&#x000a0;dermo-epidermal junction are dependent on one another, and function as a collective, as opposed to contributing individually. Protein structures are vital in maintaining the position and proximity of the dermo-epidermal junction layers. In epidermolysis bullosa, defective and deficient proteins arising from inherited or de novo genetic mutations result in&#x000a0;dermo-epidermal junction malfunction. The phenotypic severity is often proportional to the degree of protein deficiency; therefore, relatively small quantities of functional protein reduce phenotypic severity as compared to an absolute loss of protein expression.<xref ref-type="bibr" rid="article-158627.r6">[6]</xref>&#x000a0;&#x000a0;</p>
        <p>The culmination of this&#x000a0;dermo-epidermal junction malfunction is skin fragility. Erosions, blistering, and ulceration ensue in response to seemingly disproportionate mechanical trauma. The resultant wounds are frequently persistent, prone to chronic inflammation, susceptible to infection, and are associated with&#x000a0;significant pruritis, pain, and diminished quality of life.<xref ref-type="bibr" rid="article-158627.r7">[7]</xref></p>
      </sec>
      <sec id="article-158627.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Approximately 70% of&#x000a0;epidermolysis bullosa is epidermolysis bullosa simplex. Dystrophic epidermolysis bullosa&#x000a0;accounts for around 25% of all cases, and&#x000a0;junctional epidermolysis bullosa the remaining 5%.&#x000a0;Kindler epidermolysis bullosa is notably the rarest of the&#x000a0;4 epidermolysis bullosa types,&#x000a0;with only around&#x000a0;400 cases&#x000a0;reported worldwide.<xref ref-type="bibr" rid="article-158627.r8">[8]</xref><xref ref-type="bibr" rid="article-158627.r9">[9]</xref></p>
        <p>Despite the challenges in formally diagnosing&#x000a0;epidermolysis bullosa in resource-poor settings, robust epidemiological studies agree that&#x000a0;epidermolysis bullosa prevalence is around&#x000a0;10 per one million population, with incidence&#x000a0;at around 20 per one million live births.<xref ref-type="bibr" rid="article-158627.r10">[10]</xref>&#x000a0;While&#x000a0;epidermolysis bullosa appears not to be sex-preferential, trials conducted in Scottish and Middle Eastern populations suggest a geographically biased distribution; this is&#x000a0;thought&#x000a0;to be attributable to fewer germ lines within small geographical confines, and&#x000a0;sociocultural influences where consanguineous marriage is more common.<xref ref-type="bibr" rid="article-158627.r11">[11]</xref><xref ref-type="bibr" rid="article-158627.r12">[12]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-158627.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Epidermolysis Bullosa Simplex</bold>
</p>
        <p>Epidermolysis bullosa simplex&#x000a0;arises when there is a defect in genes encoding proteins governing epidermal integrity. While&#x000a0;epidermolysis bullosa simplex can be inherited in an&#x000a0;autosomal dominant or autosomal recessive pattern, the former is more common.</p>
        <p>Several&#x000a0;epidermolysis bullosa simplex subtypes exist: localized epidermolysis bullosa simplex, severe epidermolysis bullosa simplex, intermediate epidermolysis bullosa simplex, epidermolysis bullosa simplex with mottled pigmentation, migratory circinate epidermolysis bullosa simplex, intermediate epidermolysis bullosa simplex with cardiomyopathy, intermediate epidermolysis bullosa simplex with <italic toggle="yes">PLEC</italic> mutations, intermediate epidermolysis bullosa simplex with muscular dystrophy, severe epidermolysis bullosa simplex with pyloric atresia, autosomal recessive <italic toggle="yes">KRT5</italic>/<italic toggle="yes">KRT14</italic> epidermolysis bullosa simplex, BP230 deficient epidermolysis bullosa simplex, exophilin 5 deficient epidermolysis bullosa simplex, and <italic toggle="yes">CD151</italic> deficient epidermolysis bullosa simplex.<xref ref-type="bibr" rid="article-158627.r1">[1]</xref>&#x000a0;</p>
        <p>Seven mutated genes (<italic toggle="yes">KRT5</italic>,<italic toggle="yes">&#x000a0;KRT14</italic>,<italic toggle="yes"> KLHL24</italic>,<italic toggle="yes"> PLEC</italic>,<italic toggle="yes"> DST</italic>,<italic toggle="yes"> EXPH5</italic>,<italic toggle="yes"> CD151</italic>) have been isolated as causes of epidermolysis bullosa simplex. 75% of epidermolysis bullosa simplex cases&#x000a0;are due to mutations in genes <italic toggle="yes">KRT5</italic> (keratin 5 protein) and <italic toggle="yes">KRT14</italic> (keratin 14).<xref ref-type="bibr" rid="article-158627.r10">[10]</xref> Mutated keratin proteins may lack mechanical stiffness (causing proteolysis, cellular stress, and cytolysis) and exhibit thermolability (causing increased blistering in warmer temperatures).<xref ref-type="bibr" rid="article-158627.r13">[13]</xref>&#x000a0;<italic toggle="yes">PLEC</italic> (plectin), <italic toggle="yes">DST</italic> (dystonin), and&#x000a0;<italic toggle="yes">EXPH5</italic> (exophilin 5) mutations affect the hemidesmosome and potentially disrupt the keratin cytoskeleton found within basal keratinocytes. Mutated <italic toggle="yes">KLHL24</italic> and <italic toggle="yes">CD151</italic> cause a more indirect&#x000a0;disruption of keratin proteostasis.<xref ref-type="bibr" rid="article-158627.r14">[14]</xref></p>
        <p>Epidermolysis bullosa simplex thus presents with blistering, pruritis, pain, nail abnormalities, dyspigmentation, keratoderma, erosions, and scarring.<xref ref-type="bibr" rid="article-158627.r14">[14]</xref> Repeated chronic&#x000a0;insult to basal keratinocytes is thought to predispose patients to a mildly elevated incidence of basal cell carcinoma.<xref ref-type="bibr" rid="article-158627.r15">[15]</xref>&#x000a0;Affected hemidesmosomal proteins may also be expressed in extracutaneous tissues, giving rise to varied manifestations, including cardiomyopathy, respiratory tract stenosis, pyloric atresia, muscular dystrophy, esophageal involvement, and nephropathy. Failure to thrive can also be seen in severely affected children.<xref ref-type="bibr" rid="article-158627.r1">[1]</xref></p>
        <p>
<bold>Junctional Epidermolysis Bullosa</bold>
</p>
        <p>Junctional epidermolysis bullosa&#x000a0;is characterized by blistering within the plane of the lamina lucida. An autosomal recessive inheritance pattern is observed.&#x000a0;</p>
        <p>Eight&#x000a0;junctional epidermolysis bullosa subtypes have been identified: severe junctional epidermolysis bullosa; intermediate junctional epidermolysis bullosa; junctional epidermolysis bullosa with pyloric atresia; localized junctional epidermolysis bullosa; junctional epidermolysis bullosa inversa; late-onset junctional epidermolysis bullosa; laryngo-onycho-cutaneous syndrome; and junctional epidermolysis bullosa with interstitial lung disease and nephrotic syndrome.<xref ref-type="bibr" rid="article-158627.r1">[1]</xref></p>
        <p>Seven distinct mutated genes (<italic toggle="yes">LAMA3</italic>,<italic toggle="yes"> LAMB3</italic>,<italic toggle="yes"> LAMC2</italic>,<italic toggle="yes"> COL17A</italic>,<italic toggle="yes"> ITGA6</italic>,<italic toggle="yes"> ITGB4</italic>,<italic toggle="yes"> ITGA3</italic>)&#x000a0;account for junctional epidermolysis bullosa. Mutations in either&#x000a0;<italic toggle="yes">LAMA3</italic>, <italic toggle="yes">LAMB3</italic>, or&#x000a0;<italic toggle="yes">LAMC2</italic>&#x000a0;result in a malfunctioning laminin 332 protein,&#x000a0;hindering anchoring filament function and keratinocyte migration during wound healing.<xref ref-type="bibr" rid="article-158627.r16">[16]</xref> Additionally, laminin 332&#x000a0;maintains&#x000a0;epithelial&#x000a0;function in the&#x000a0;brain, eyes, lungs, kidneys, thymus, and gastrointestinal tract, explaining why&#x000a0;dysfunction produces an array of extracutaneous complications. The absolute absence of laminin 332 in severe junctional epidermolysis bullosa creates&#x000a0;extreme epithelial fragility, and severe granulation tissue within the airways can cause respiratory compromise, often limiting&#x000a0;survival beyond&#x000a0;2 years of age. <italic toggle="yes">COL17A</italic> mutations create faulty collagen XVII proteins, which maintain hair follicle stem cells, melanocyte stem cells, cell mobility, and cell migration; consequently,&#x000a0;skin atrophy, hair loss, dyspigmentation, and carcinogenesis ensue.<xref ref-type="bibr" rid="article-158627.r17">[17]</xref> Malfunctioning integrin proteins form&#x000a0;due&#x000a0;to mutations in <italic toggle="yes">ITGA6</italic>, <italic toggle="yes">ITGB4</italic>, and <italic toggle="yes">ITGA3</italic> genes. The resultant defective proteins alter cell-matrix adhesion, hemidesmosome, and keratinocyte function, ligand banding, and cell signaling, resulting in&#x000a0;severe mucocutaneous fragility, overgranulation, and nail dystrophy. Their&#x000a0;malfunction in the gastrointestinal mucosa results in&#x000a0;pyloric atresia, while their impact on renal podocytes and alveolar epithelial cells&#x000a0;propagates nephropathy and interstitial lung disease.<xref ref-type="bibr" rid="article-158627.r18">[18]</xref><xref ref-type="bibr" rid="article-158627.r19">[19]</xref></p>
        <p>Repeated injury in the lamina lucida increases&#x000a0;squamous cell carcinoma risk, significantly contributing to early mortality in&#x000a0;the junctional epidermolysis bullosa population.<xref ref-type="bibr" rid="article-158627.r20">[20]</xref> Additionally, the proteins affected in junctional epidermolysis bullosa also play vital roles in&#x000a0;the odontogenic epithelium; tooth enamel defects are therefore seen in all patients with junctional epidermolysis bullosa.<xref ref-type="bibr" rid="article-158627.r21">[21]</xref></p>
        <p>
<bold>Dystrophic Epidermolysis Bullosa</bold>
</p>
        <p>Dystrophic epidermolysis bullosa&#x000a0;may be inherited in autosomal dominant or recessive patterns, with the latter giving rise to more severe phenotypes. Dystrophic epidermolysis bullosa features fragility below the lamina densa due to mutant&#x000a0;<italic toggle="yes">COL7A1</italic> (collagen VII protein).<xref ref-type="bibr" rid="article-158627.r22">[22]</xref></p>
        <p>Four types of dominant&#x000a0;dystrophic epidermolysis bullosa have been identified: intermediate dominant&#x000a0;dystrophic epidermolysis bullosa, localized dominant&#x000a0;dystrophic epidermolysis bullosa, dominant&#x000a0;dystrophic epidermolysis bullosa pruriginosa, and self-improving dominant&#x000a0;dystrophic epidermolysis bullosa. Six types of&#x000a0;recessive dystrophic epidermolysis bullosa have been identified: intermediate recessive dystrophic epidermolysis bullosa, severe recessive dystrophic epidermolysis bullosa, recessive dystrophic epidermolysis bullosa inversa, localized recessive dystrophic epidermolysis bullosa, recessive dystrophic epidermolysis bullosa pruriginosa, and self-improving recessive dystrophic epidermolysis bullosa. One final subtype, severe dystrophic epidermolysis bullosa, features dominant and recessive compound heterozygosity.<xref ref-type="bibr" rid="article-158627.r1">[1]</xref></p>
        <p>Deficiency in type VII collagen manifests with&#x000a0;skin fragility, blistering, scarring, milia, and mucosal&#x000a0;involvement. While all&#x000a0;4 types of&#x000a0;epidermolysis bullosa cause repeated blistering, dystrophic epidermolysis bullosa features a defect much deeper in the dermo-epidermal junction, propagating profound&#x000a0;mucocutaneous scarring and&#x000a0;fibrosis.<xref ref-type="bibr" rid="article-158627.r23">[23]</xref><xref ref-type="bibr" rid="article-158627.r24">[24]</xref> Eventually, this significantly disables patients with&#x000a0;contractures and&#x000a0;pseudosyndactyly and encourages&#x000a0;aggressive, metastatic&#x000a0;squamous cell carcinoma&#x000a0;development, the latter often proving fatal.<xref ref-type="bibr" rid="article-158627.r25">[25]</xref><xref ref-type="bibr" rid="article-158627.r26">[26]</xref></p>
        <p><bold>Kindler Epidermolysis Bullosa</bold>&#x000a0;</p>
        <p>Kindler epidermolysis bullosa&#x000a0;is a consequence of an&#x000a0;autosomal recessive defect&#x000a0;in the <italic toggle="yes">FERMT1</italic> gene, which produces faulty kindlin-1 proteins.&#x000a0;This alters&#x000a0;keratinocyte cytoskeleton maintenance and integrin activation. In Kindler epidermolysis bullosa, blistering may occur in any plane of the dermo-epidermal junction.<xref ref-type="bibr" rid="article-158627.r9">[9]</xref></p>
        <p>Due to defective kindlin-1, cutaneous mechanical trauma propagates cellular stress in keratinocytes.&#x000a0;Consequently,&#x000a0;an&#x000a0;influx of growth factors and cytokines encourages dermal fibroblasts to over-synthesize the extracellular matrix, resulting in&#x000a0;scarring and fibrosis. Uniquely amongst EB subtypes, Kindler epidermolysis bullosa features photosensitivity, with&#x000a0;reduced kindlin-1 linked to UVB-mediated apoptosis.<xref ref-type="bibr" rid="article-158627.r27">[27]</xref></p>
        <p>While childhood Kindler epidermolysis bullosa features&#x000a0;blistering and photosensitivity, these symptoms eventually give way to&#x000a0;poikiloderma, dyspigmentation, atrophy, erythema, mucocutaneous scarring and palmoplantar hyperkeratosis. Later in adulthood, epithelial cancers complicate Kindler epidermolysis bullosa, with squamous cell carcinoma typically presenting at acral and mucosal sites.<xref ref-type="bibr" rid="article-158627.r28">[28]</xref> Beyond cutaneous expression, patients may suffer from&#x000a0;gingivitis, esophageal&#x000a0;stenosis, and colitis due to kindlin-1 protein utility in the&#x000a0;oral mucosa and gastrointestinal tract.&#x000a0;</p>
      </sec>
      <sec id="article-158627.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Standard light microscopy is not relevant in diagnosing epidermolysis bullosa, as insufficient resolution and a failure to discriminate key ultrastructural diagnostic features can lead to misdiagnosis.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-158627.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Epidermolysis bullosa initially presents at birth or early childhood. Common presenting complaints include blistering, skin fragility, and non-healing wounds disproportionate to&#x000a0;mechanical trauma. A family history of similar&#x000a0;complaints may be present. Additionally, pain&#x000a0;and pruritis&#x000a0;are common concerns. Blistering is distributed with bias for&#x000a0;sites prone to&#x000a0;pressure and friction, with the hands, feet, buttocks, and knees most susceptible. In neonates, infants, or children, the nappy&#x000a0;region is&#x000a0;also susceptible.<xref ref-type="bibr" rid="article-158627.r29">[29]</xref> When&#x000a0;epidermolysis bullosa is diagnosed later in life, it is milder or localized&#x000a0;epidermolysis bullosa subtypes that are identified.<xref ref-type="bibr" rid="article-158627.r30">[30]</xref></p>
        <p>As&#x000a0;epidermolysis bullosa is a genetically heterozygous group of disorders, a&#x000a0;broad phenotypic range is recognized.<xref ref-type="bibr" rid="article-158627.r31">[31]</xref> The exact&#x000a0;epidermolysis bullosa subtype dictates symptom distribution and severity. Subtle distinctions in the&#x000a0;phenotype can be challenging to differentiate by clinical examination alone. Definitive diagnosis may be possible with specialized evaluation, including electron and immunofluorescence microscopy and genetic mutational analyses. Some classical subtypes are easily identifiable:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acrally distributed blistering with keratoderma is the hallmark of localized epidermolysis bullosa simplex.</p>
          </list-item>
          <list-item>
            <p>Confluent&#x000a0;palmoplantar keratoderma features in severe epidermolysis bullosa simplex, with clustered arcuate herpetiform blisters.</p>
          </list-item>
          <list-item>
            <p>Neonates with a hoarse cry who develop overgranulation in the&#x000a0;perioral, neck, and axillary areas and tooth enamel defects are likely to have junctional epidermolysis bullosa.</p>
          </list-item>
          <list-item>
            <p>Severe&#x000a0;dystrophic epidermolysis bullosa features profound scarring causing microstomia, loss of linguinal papillae, digital contractures, and pseudosyndactyly.</p>
          </list-item>
          <list-item>
            <p>Kindler epidermolysis bullosa&#x000a0;is distinct in displaying photosensitivity and features poikiloderma.<xref ref-type="bibr" rid="article-158627.r9">[9]</xref><xref ref-type="bibr" rid="article-158627.r24">[24]</xref><xref ref-type="bibr" rid="article-158627.r32">[32]</xref></p>
          </list-item>
        </list>
        <p>The mode of inheritance (and therefore possible subtype) and consanguinity-related risk may be gleaned&#x000a0;by establishing a thorough family history.&#x000a0;</p>
        <p>As mentioned previously, extracutaneous involvement is an important&#x000a0;contributor to&#x000a0;epidermolysis bullosa morbidity and mortality. The manifestations, as&#x000a0;outlined in Figure&#x000a0;<bold>1,</bold>&#x000a0;are varied, and their combination and severity are&#x000a0;governed&#x000a0;by specific genotypes.<xref ref-type="bibr" rid="article-158627.r2">[2]</xref><xref ref-type="bibr" rid="article-158627.r3">[3]</xref> Given the broad phenotypic range seen in extracutaneous disease, including a detailed history and&#x000a0;physical examination is imperative. This will inform both the assessment and plan for treating clinicians.&#x000a0;</p>
      </sec>
      <sec id="article-158627.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Transmission Electron Microscopy and Immunofluorescence Antigen Mapping</bold>
</p>
        <p>Transmission electron microscopy and immunofluorescence antigen mapping are undertaken upon shave biopsy specimens from non-blistered skin subjected to gentle friction before the study. This is to induce progressive morphological changes of early blistering.&#x000a0;Blistered skin is not used as reparative changes can lead to misdiagnosis.<xref ref-type="bibr" rid="article-158627.r33">[33]</xref></p>
        <p>Following a biopsy, transmission electron microscopy, and&#x000a0;immunofluorescence antigen mapping are vital in distinguishing&#x000a0;the affected&#x000a0;dermo-epidermal junction plane and morphological features specific to&#x000a0;epidermolysis bullosa&#x000a0;subtypes. Transmission electron microscopy details the planar location of the dermo-epidermal junction defect and morphological features (desmosomes, hemidesmosomes, anchoring filaments, fibrils, sub-basal dense plates, basal keratin filaments) aiding subtype diagnosis.<xref ref-type="bibr" rid="article-158627.r34">[34]</xref> Conventional light microscopy reveals fewer fine details at the basement membrane zone and, therefore, has no diagnostic role in the setting of epidermolysis bullosa.&#x000a0;Immunofluorescence antigen mapping&#x000a0;and transmission electron microscopy&#x000a0;help&#x000a0;subtype epidermolysis bullosa by highlighting target antigens and quantifying their abundance (which shows a correlation with phenotypic severity).<xref ref-type="bibr" rid="article-158627.r35">[35]</xref> Limitations of these processes are appreciated in resource-poor settings, given the cost, time, and expertise required.&#x000a0;&#x000a0;</p>
        <p>
<bold>Genetic&#x000a0;Screening</bold>
</p>
        <p>Genetic screening can confirm the epidermolysis bullosa subtype. Next-generation sequencing has surpassed&#x000a0;Sanger sequencing in&#x000a0;epidermolysis bullosa diagnosis due to its lower cost, concurrent multiple gene screening efficiency, and&#x000a0;operator-friendly data synthesis.<xref ref-type="bibr" rid="article-158627.r36">[36]</xref><xref ref-type="bibr" rid="article-158627.r37">[37]</xref>&#x000a0;Mutational analyses also underpin genetic counseling for family members and may inform future family planning.</p>
      </sec>
      <sec id="article-158627.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The absence of curative therapies has led to medical management oriented on supportive care, symptom control, and prevention of mild to severe complications.<xref ref-type="bibr" rid="article-158627.r29">[29]</xref> Interdisciplinary management is necessary, guided by the subtype of EB that is diagnosed.</p>
        <p>In epidermolysis bullosa, blisters are prevented by reducing exposure to&#x000a0;mechanical&#x000a0;trauma. Trauma provoked by&#x000a0;cord clamps, clothing labels and seams, plastic patient identifying bands, and heel prick tests should be minimized in neonates. Hot, humid environments may also aggravate fragility.<xref ref-type="bibr" rid="article-158627.r38">[38]</xref> Trauma-preventative dressings placed over body sites are more likely to meet with pressure or friction. Blisters&#x000a0;may be pierced with sterile needles and drained, with the blister roof kept intact to&#x000a0;minimize pain and prevent microbial colonization. Broken skin can be dressed with specialized non-adhesive foam and lipocolloid dressings.<xref ref-type="bibr" rid="article-158627.r39">[39]</xref></p>
        <p>To reduce colonization, antiseptic washes, and ointments may be encouraged. Targeted antibiotic use should be reserved for proven infection, frank cellulitis, and sepsis management.<xref ref-type="bibr" rid="article-158627.r40">[40]</xref> Wound overgranulation may be&#x000a0;managed with short-term topical corticosteroid use.<xref ref-type="bibr" rid="article-158627.r41">[41]</xref></p>
        <p>Squamous cell carcinoma&#x000a0;is frequently a devastating complication in epidermolysis bullosa and notably a common cause of&#x000a0;early mortality&#x000a0;in&#x000a0;junctional epidermolysis bullosa and&#x000a0;dystrophic epidermolysis bullosa populations.<xref ref-type="bibr" rid="article-158627.r42">[42]</xref> Wide local excision&#x000a0;remains the recommended management; however,&#x000a0;squamous cell carcinoma&#x000a0;in&#x000a0;epidermolysis bullosa is aggressive and highly metastatic regardless of conventional tumor histological grading or margin of surgical clearance. In severe recessive dystrophic epidermolysis bullosa, the risk of mortality due to&#x000a0;squamous cell carcinoma&#x000a0;rises&#x000a0;to&#x000a0;78.8%&#x000a0;at 55 years old from&#x000a0;38.7%&#x000a0;at 35 years old, and the median survival&#x000a0;is approximately&#x000a0;5 years following initial&#x000a0;squamous cell carcinoma diagnosis.<xref ref-type="bibr" rid="article-158627.r15">[15]</xref> Radiotherapy and chemotherapy can form palliative treatment options.&#x000a0;Newer immunotherapy agents have been employed with varying degrees of success.</p>
        <p>Pain is an important overarching symptom.<xref ref-type="bibr" rid="article-158627.r43">[43]</xref> The source of pain may be the cutaneous disease, the extracutaneous manifestations, or secondary to wound dressing changes or bathing. Analgesia, involvement of&#x000a0;a pain management team, and psychological support should aim to reduce pain, which frequently debilitates a patient's quality of life. Neuropathic pain medication can play a role in managing pruritic pain symptoms unresolved by emollient, topical corticosteroid, and antihistamine therapy.<xref ref-type="bibr" rid="article-158627.r44">[44]</xref>&#x000a0;</p>
        <p>Very recently,&#x000a0;beremagene geperpavec ('B-VEC'), a&#x000a0;dosable topical gene therapy delivering&#x000a0;<italic toggle="yes">COL7A1</italic>&#x000a0;using&#x000a0;herpes simplex virus type 1 as a vector, has&#x000a0;been approved by the FDA as a treatment for dystrophic epidermolysis bullosa.<xref ref-type="bibr" rid="article-158627.r45">[45]</xref>&#x000a0;Similarly, Oleogel-S10 (birch triterpene extract), a herbal gel remedy was recently approved by some regulatory authorities for wound management in junctional and dystrophic epidermolysis bullosa.</p>
      </sec>
      <sec id="article-158627.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is essential to rule out possible differential diagnoses, particularly in neonatal populations:</p>
        <p><bold>Pompholyx Eczema</bold>&#x000a0;presents with acral pruritic blistering. A history of atopy may be present. Patch testing may be indicated to identify delayed hypersensitivity reactions to contact allergens.<xref ref-type="bibr" rid="article-158627.r46">[46]</xref></p>
        <p><bold>Porphyria&#x000a0;</bold>presents with scarring, milia, and photosensitivity, with possible hypertrichosis. Skin biopsies and porphyrin testing may be indicated.<xref ref-type="bibr" rid="article-158627.r47">[47]</xref></p>
        <p><bold>Bullous Pemphigoid&#x000a0;</bold>presents with large, tense bullae and itch. Clinical examination and skin biopsy can confirm bullous pemphigoid.<xref ref-type="bibr" rid="article-158627.r48">[48]</xref></p>
        <p><bold>Bullous Systemic Lupus Erythematosus&#x000a0;</bold>presents with tense vesicles, bullae, and erosions, often in sun-exposed areas. Histopathology and immunofluorescence confirm this differential.<xref ref-type="bibr" rid="article-158627.r49">[49]</xref></p>
        <p><bold>Bullous Tinea Pedis</bold>&#x000a0;presents with multilocular pedal blistering, with possible skin maceration between digits. Tinea pedis is diagnosed through mycological cultures from skin scrapings.<xref ref-type="bibr" rid="article-158627.r50">[50]</xref></p>
        <p><bold>Palmoplantar Keratoderma&#x000a0;</bold>causes&#x000a0;acral skin thickening, often with nail dystrophy. Genetic testing may be indicated, though acquired palmoplantar keratoderma may be associated with internal malignancy, thyroid abnormalities, inflammatory dermatoses such as lichen planus, and certain medications.<xref ref-type="bibr" rid="article-158627.r51">[51]</xref></p>
        <p><bold>Epidermolysis Bullosa Acquisita</bold>&#x000a0;is an autoimmune disorder that may present similarly to dystrophic epidermolysis bullosa but later in life. Immunofluorescence studies on skin biopsies are indicated.<xref ref-type="bibr" rid="article-158627.r52">[52]</xref></p>
        <p><bold>Ehlers-Danlos Syndrome&#x000a0;</bold>features joint hypermobility, hyperextensible skin, and easy bruising with skin fragility. Ehlers Danlos is diagnosed by skin biopsy and genetic testing.<xref ref-type="bibr" rid="article-158627.r53">[53]</xref></p>
        <p><bold>Incontinentia Pigmenti&#x000a0;</bold>features Blaschkoid vesicles forming hyperpigmented verrucous whorls.<xref ref-type="bibr" rid="article-158627.r54">[54]</xref></p>
      </sec>
      <sec id="article-158627.s10" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Current clinical trials study the potential of&#x000a0;a broad range of therapeutic strategies.<xref ref-type="bibr" rid="article-158627.r55">[55]</xref></p>
        <p>Studies on gene replacement therapy explore how <italic toggle="yes">COL7A1</italic> can be delivered cutaneously to&#x000a0;patients with recessive dystrophic epidermolysis bullosa.<xref ref-type="bibr" rid="article-158627.r56">[56]</xref>&#x000a0;Recently,&#x000a0;beremagene geperpavec ('B-VEC'), a topical gene therapy delivering <italic toggle="yes">COL7A1</italic> using&#x000a0;herpes simplex virus type 1 as a vector, has&#x000a0;been approved by regulatory authorities.<xref ref-type="bibr" rid="article-158627.r45">[45]</xref>&#x000a0;Other gene replacement therapy trials explore the efficacy&#x000a0;of&#x000a0;<italic toggle="yes">COL7A1</italic> transgenes and self-inactivating viral vectors&#x000a0;expressing&#x000a0;type VII&#x000a0;collagen, which 'correct' cells ex-vivo before being reintroduced to patients cutaneously.&#x000a0;Studies examining the effectiveness of grafting revertant skin to lesions in&#x000a0;junctional epidermolysis bullosa suggest the potential of revertant mosaicism as a natural gene replacement therapy.<xref ref-type="bibr" rid="article-158627.r57">[57]</xref>&#x000a0;CRISPR/Cas9 technology has shown promise in gene-editing studies involving correcting <italic toggle="yes">COL7A1</italic> mutations in fibroblasts and keratinocytes in mice.<xref ref-type="bibr" rid="article-158627.r58">[58]</xref>&#x000a0;Pre-clinical studies on exon-skipping in <italic toggle="yes">COL7A1</italic> and <italic toggle="yes">COL17A1</italic> genes show the effective formation of partly-functioning proteins, indicating another potential therapeutic strategy.<xref ref-type="bibr" rid="article-158627.r55">[55]</xref>&#x000a0;The use of induced pluripotent stem cells can encourage the expansion of genetically altered cells ex-vivo to produce sufficient skin grafts for patients.<xref ref-type="bibr" rid="article-158627.r59">[59]</xref></p>
        <p>Repurposing existing therapies has also shown promise. When repurposed for junctional and dystrophic epidermolysis bullosa treatment, gentamycin, an aminoglycoside antibiotic, can 'read through' stop codon mutations in <italic toggle="yes">COL7A1</italic> and <italic toggle="yes">LAMB3&#x000a0;</italic>when administered topically or intravenously, enabling the synthesis of full-length proteins.<xref ref-type="bibr" rid="article-158627.r60">[60]</xref><xref ref-type="bibr" rid="article-158627.r61">[61]</xref>&#x000a0;Losartan, an angiotensin II receptor blocker,&#x000a0;has shown improvement in inflammation, fibrosis, and tumor progression&#x000a0;by altering&#x000a0;TGF-beta signaling in dystrophic epidermolysis bullosa.<xref ref-type="bibr" rid="article-158627.r62">[62]</xref>&#x000a0;A trial investigating the repurposing&#x000a0;of apremilast (a&#x000a0;phosphodiesterase type-4 inhibitor currently used in psoriasis management) in epidermolysis bullosa simplex is underway.<xref ref-type="bibr" rid="article-158627.r63">[63]</xref>&#x000a0;Oleogel-S10 (birch triterpene extract), a herbal gel remedy recently approved by regulating authorities for junctional and dystrophic epidermolysis bullosa management, has demonstrated accelerated wound healing by altering pro-inflammatory mediator regulation, increasing migration of primary human keratinocytes and promoting keratinocyte differentiation.<xref ref-type="bibr" rid="article-158627.r64">[64]</xref><xref ref-type="bibr" rid="article-158627.r65">[65]</xref></p>
        <p>Ongoing protein therapy studies observe the efficacy of&#x000a0;topical and intravenous recombinant type VII collagen in&#x000a0;promoting wound healing, and HMGB1 proteins in&#x000a0;suppressing inflammation by mobilizing cells from the bone marrow to damaged tissue.<xref ref-type="bibr" rid="article-158627.r66">[66]</xref><xref ref-type="bibr" rid="article-158627.r67">[67]</xref><xref ref-type="bibr" rid="article-158627.r66">[66]</xref></p>
        <p>Literature on the management of squamous cell carcinoma in epidermolysis bullosa is limited. Case studies indicate that cetuximab, an epidermal growth factor receptor inhibitor, increases progression-free survival of head and neck squamous cell carcinoma.<xref ref-type="bibr" rid="article-158627.r68">[68]</xref>&#x000a0;Meanwhile, little research exists on the effectiveness of immune checkpoint inhibitors, such as&#x000a0;nivolumab, pembrolizumab, and cemiplimab.<xref ref-type="bibr" rid="article-158627.r55">[55]</xref>&#x000a0;Rigosertib, a multikinase inhibitor, has so far shown successful apoptosis induction in recessive epidermolysis bullosa without impact on carcinoma-free keratinocytes.<xref ref-type="bibr" rid="article-158627.r69">[69]</xref>&#x000a0;&#x000a0;</p>
        <p>Advancement in&#x000a0;epidermolysis bullosa trials requires a focus on&#x000a0;epidermolysis bullosa severity scoring. While numerous severity scoring tools exist, the absence of a universally utilized tool creates&#x000a0;discord when comparing epidermolysis bullosa&#x000a0;severity and assessing symptomatic progression and remission.<xref ref-type="bibr" rid="article-158627.r70">[70]</xref> A global initiative to develop a universal tool is in progress.</p>
      </sec>
      <sec id="article-158627.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis in&#x000a0;epidermolysis bullosa is variable and dictated by the specific causative subtype and the complications arising from cutaneous and extracutaneous manifestations.<xref ref-type="bibr" rid="article-158627.r71">[71]</xref> In some subtypes, particularly those that are milder,&#x000a0;epidermolysis bullosa has&#x000a0;minimal impact on life expectancy. In other, more severe subtypes, infantile&#x000a0;or childhood mortality is highly prevalent. For example, most patients with severe&#x000a0;junctional epidermolysis bullosa will rarely survive beyond&#x000a0;2 years of age, and severe&#x000a0;recessive dystrophic epidermolysis bullosa patients often face mortality in the third to fifth decades of life due to the development of aggressive squamous cell carcinoma.<xref ref-type="bibr" rid="article-158627.r72">[72]</xref><xref ref-type="bibr" rid="article-158627.r73">[73]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-158627.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Interprofessional discussion should be prompted following diagnosis,&#x000a0;guided by the specific extracutaneous complications present in the patient.&#x000a0;</p>
        <p>
<bold>Oral and Gastrointestinal Disease</bold>
</p>
        <p>Repeated blistering, erosion, ulceration, and scarring in the oral mucosa secondary to dysfunctional&#x000a0;laminin 332, kindlin-1, and&#x000a0;types VII and XVII collagen can cause microstomia, tongue-tethering and vestibular sulcus loss.&#x000a0;Junctional epidermolysis bullosa additionally features tooth enamel defect. Combined, these concerns increase the likelihood of dental caries formation due to difficulty maintaining oral hygiene.<xref ref-type="bibr" rid="article-158627.r74">[74]</xref><xref ref-type="bibr" rid="article-158627.r75">[75]</xref> Management may&#x000a0;include dental scaling, root planning, and antibiotic therapy.&#x000a0;</p>
        <p>Nutrition is impacted by the aforementioned oral manifestations, as well as gastrointestinal involvement. Esophageal blistering contributes to poor nutrition by causing dysphagia. This is managed using analgesia, soft diet alteration, and occasionally inhaled steroids to reduce localized edema and erosion. Esophageal webbing and stricturing (including secondary to&#x000a0;squamous cell carcinoma&#x000a0;formation)&#x000a0;hinder proper nutrition due to&#x000a0;dysphagia and reflux symptoms. Non-malignant esophageal complications may warrant balloon dilation and proton pump inhibitor therapy.<xref ref-type="bibr" rid="article-158627.r76">[76]</xref> Neonatal patients with pyloric atresia cannot develop nutrition at all without immediate surgical intervention.<xref ref-type="bibr" rid="article-158627.r77">[77]</xref> Failure to thrive may be seen, together with vitamin and mineral deficiencies, anemia, hypoalbuminemia, delayed puberty, and poor wound healing. Long-term management warrants specialist dietician support and consideration of gastrostomy placement.<xref ref-type="bibr" rid="article-158627.r78">[78]</xref></p>
        <p>Poor nutritional intake, alongside gastrointestinal and cutaneous losses, leads to microcytic or normocytic anemias, notably iron deficiency anemia or anemia of chronic disease.<xref ref-type="bibr" rid="article-158627.r79">[79]</xref> Iron supplementation is an important consideration. Transfusion may be required in symptomatic anemia if iron is depleted.&#x000a0;Intravenous iron infusion&#x000a0;is preferred to oral supplementation, which can cause constipation. Other causes of constipation in&#x000a0;epidermolysis bullosa&#x000a0;include regular opioid use, poor fiber and fluid intake, and anal blistering. An osmotic laxative and dietary alteration can be prescribed&#x000a0;prophylactically to manage constipation.<xref ref-type="bibr" rid="article-158627.r80">[80]</xref></p>
        <p>
<bold>Musculoskeletal Disease</bold>
</p>
        <p>Patients with&#x000a0;epidermolysis bullosa have an increased risk of developing osteopenia and osteoporosis due to reduced mobility, unresolved inflammation, vitamin D deficiency, pubertal delay, and chronic opioid exposure.<xref ref-type="bibr" rid="article-158627.r81">[81]</xref> Consequently, vitamin D supplements, physiotherapy, and induction of puberty may be considered&#x000a0;when managing&#x000a0;bone health. With regard to soft tissues, repeated blistering may propagate flexion contracture and pseudosyndactyly formation, significantly impacting manual dexterity and gait. Surgical release may be indicated to improve functionality if preventative measures, such as&#x000a0;digit-separating&#x000a0;dressings, physiotherapy, and podiatrist involvement, fail.<xref ref-type="bibr" rid="article-158627.r82">[82]</xref><xref ref-type="bibr" rid="article-158627.r83">[83]</xref> In subtypes with muscular dystrophy, only supportive therapy is recommended.<xref ref-type="bibr" rid="article-158627.r84">[84]</xref></p>
        <p>
<bold>Ophthalmic Involvement</bold>
</p>
        <p>While ophthalmological input is recommended for complications such as blepharitis, erosion, scarring, keratitis, symblepharon, and ectropion, lubricating preparations&#x000a0;are recommended as prophylactic management.&#x000a0;Around&#x000a0;6% of patients with&#x000a0;recessive dystrophic epidermolysis bullosa develop&#x000a0;blindness due to ophthalmic involvement.<xref ref-type="bibr" rid="article-158627.r85">[85]</xref><xref ref-type="bibr" rid="article-158627.r86">[86]</xref></p>
        <p>
<bold>Genitourinary Involvement</bold>
</p>
        <p>Genito-urinary&#x000a0;epidermolysis bullosa involvement includes stenosis of the urethra (causing hydroureter and hydronephrosis if unresolved), for which surgical stenting may be indicated.<xref ref-type="bibr" rid="article-158627.r87">[87]</xref> Vaginal stenosis may also complicate epidermolysis bullosa.<xref ref-type="bibr" rid="article-158627.r88">[88]</xref>&#x000a0;Hemodialysis, peritoneal dialysis,&#x000a0;and eventual transplantation may be warranted in epidermolysis bullosa-related&#x000a0;IgA nephropathy, post-streptococcal glomerulonephritis, and renal amyloidosis.<xref ref-type="bibr" rid="article-158627.r89">[89]</xref></p>
        <p>
<bold>Cardiovascular and Respiratory Involvement</bold>
</p>
        <p><italic toggle="yes">KLHL</italic> mutations causing dilated and hypertrophic cardiomyopathy&#x000a0;require&#x000a0;specialist cardiology input.<xref ref-type="bibr" rid="article-158627.r90">[90]</xref> Interstitial lung disease confers a poor prognosis.<xref ref-type="bibr" rid="article-158627.r91">[91]</xref> Laryngeal involvement requires emergent airway management.<xref ref-type="bibr" rid="article-158627.r92">[92]</xref></p>
        <p>
<bold>Psychosocial Impact</bold>
</p>
        <p>Epidermolysis bullosa&#x000a0;is a frequently debilitating disease without a cure and has the potential to exert considerable psychological impact.<xref ref-type="bibr" rid="article-158627.r93">[93]</xref> Chronic wounds, pain, itch, reduced mobility, and difficult social interaction can contribute to a markedly reduced quality of life.<xref ref-type="bibr" rid="article-158627.r26">[26]</xref> The societal, familial, and financial consequences extend to caregivers, particularly&#x000a0;those&#x000a0;who are also relatives.<xref ref-type="bibr" rid="article-158627.r94">[94]</xref> Psychological&#x000a0;support may improve the emotional well-being of patients and caregivers.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-158627.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As&#x000a0;epidermolysis bullosa has genetic etiology, only genetic counseling, prenatal screening, and preimplantation screening can inform whether offspring&#x000a0;could be affected.<xref ref-type="bibr" rid="article-158627.r95">[95]</xref><xref ref-type="bibr" rid="article-158627.r96">[96]</xref> While genetic counseling predicts the mode of inheritance and the likelihood of&#x000a0;epidermolysis bullosa transmission to offspring, prenatal screening&#x000a0;employs chorionic villus sampling or amniocentesis to guide expecting parents on inheritance risk.<xref ref-type="bibr" rid="article-158627.r97">[97]</xref> Chorionic&#x000a0;villus sampling is an effective method of screening though it carries a higher risk of miscarriage. Preimplantation screening and haplotyping identify mutations in early embryos and oocytes, respectively, allowing for genetically unaffected fertilization.<xref ref-type="bibr" rid="article-158627.r98">[98]</xref></p>
      </sec>
      <sec id="article-158627.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Given that&#x000a0;epidermolysis bullosa is presently incurable, the aims of current care are orientated around early and accurate&#x000a0;diagnosis, information on prognosis, symptom relief, quality of life, prevention of complications, and genetic counseling.<xref ref-type="bibr" rid="article-158627.r99">[99]</xref> Patients are generally managed in many settings. Though&#x000a0;stable patients&#x000a0;are&#x000a0;usually managed in outpatient facilities, acute complications may require specialist assessment.&#x000a0;</p>
        <p>Based on severity, patients with&#x000a0;epidermolysis bullosa should&#x000a0;be scheduled for regular follow-up, at a minimum of annual, coordinated with their primary care clinician. A complete skin examination, with photography to monitor suspicious lesions,&#x000a0;is recommended. The frequency of home visits by a specialist nurse is&#x000a0;determined by phenotypic severity. Patients should be prescribed a supply of wound dressings as part of their prescription.&#x000a0;</p>
        <p>The&#x000a0;epidermolysis bullosa&#x000a0;team will almost always comprise a dermatologist and specialist nurse in coordination with primary care. There are several key members of the interdisciplinary team, depending on the phenotype, including general practitioners, pediatricians, podiatrists, oncologists, plastic surgeons, palliative care specialists, pain management specialists, psychologists, dentists, ophthalmologists, occupational therapists, physiotherapists, dietitians, gastroenterologists, urologists, speech and language specialists, otolaryngologists, cardiologists, endocrinologists, and orthotics. Multidisciplinary team meetings&#x000a0;help to coordinate these interspecialty efforts.<xref ref-type="bibr" rid="article-158627.r98">[98]</xref><xref ref-type="bibr" rid="article-158627.r100">[100]</xref></p>
      </sec>
      <sec id="article-158627.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=158627&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=158627">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/epidermolysis-bullosa/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=158627">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/158627/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=158627">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-158627.s16">
        <fig id="article-158627.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Extracutaneous manifestations of epidermolysis bullosa Contributed by Dr Ajoy Bardhan</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Extracutaneous__manifestations__of__EB" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-158627.s17">
        <fig id="article-158627.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Plantar blistering and keratoderma in Epidermolysis Bullosa Simplex. Contributed by Dr Ajoy Bardhan BSc FRCP and Prof Adrian Heagerty BSc MD FRCP. Obtained with informed consent.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EBS__feet" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-158627.s18">
        <fig id="article-158627.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Pseudosyndactyly and ulceration of the lower limb in Recessive Dystrophic Epidermolysis Bullosa Contributed by Dr Ajoy Bardhan BSc FRCP and Prof Adrian Heagerty BSc MD FRCP. Obtained with informed consent.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="RDEB__foot" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-158627.s19">
        <fig id="article-158627.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Truncal erosions and inflammation in Junctional Epidermolysis Bullosa. Contributed by Dr Ajoy Bardhan BSc FRCP and Prof Adrian Heagerty BSc MD FRCP. Obtained with informed consent.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JEB__trunk" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-158627.s20">
        <title>References</title>
        <ref id="article-158627.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bardhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chapple</surname>
                <given-names>ILC</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Magin</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Polson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heagerty</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Epidermolysis bullosa.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2020</year>
            <month>Sep</month>
            <day>24</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <pub-id pub-id-type="pmid">32973163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>367</fpage>
            <page-range>367-84; quiz 385-6</page-range>
            <pub-id pub-id-type="pmid">19700010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>387</fpage>
            <page-range>387-402; quiz 403-4</page-range>
            <pub-id pub-id-type="pmid">19700011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Bodemer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bolling</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Diem</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Heagerty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hovnanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Palisson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schwieger-Briel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sprecher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tamai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Woodley</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Zambruno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.</article-title>
            <source>Br J Dermatol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>183</volume>
            <issue>4</issue>
            <fpage>614</fpage>
            <page-range>614-627</page-range>
            <pub-id pub-id-type="pmid">32017015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vahidnezhad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Youssefian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa.</article-title>
            <source>Matrix Biol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>57-58</volume>
            <fpage>76</fpage>
            <page-range>76-85</page-range>
            <pub-id pub-id-type="pmid">27496350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Pulkkinen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pfendner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.</article-title>
            <source>Hum Genet</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-51</page-range>
            <pub-id pub-id-type="pmid">11810295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nystr&#x000f6;m</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Injury- and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa.</article-title>
            <source>Matrix Biol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>68-69</volume>
            <fpage>547</fpage>
            <page-range>547-560</page-range>
            <pub-id pub-id-type="pmid">29391280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petrof</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papanikolaou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bardhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Heagerty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ogboli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chiswell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database.</article-title>
            <source>Br J Dermatol</source>
            <year>2022</year>
            <month>May</month>
            <volume>186</volume>
            <issue>5</issue>
            <fpage>843</fpage>
            <page-range>843-848</page-range>
            <pub-id pub-id-type="pmid">34927719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Youssefian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vahidnezhad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Kindler Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2016</year>
            <month>3</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">26937547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry.</article-title>
            <source>JAMA Dermatol</source>
            <year>2016</year>
            <month>Nov</month>
            <day>01</day>
            <volume>152</volume>
            <issue>11</issue>
            <fpage>1231</fpage>
            <page-range>1231-1238</page-range>
            <pub-id pub-id-type="pmid">27463098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horn</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Priestley</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Eady</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Tidman</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of epidermolysis bullosa in Scotland.</article-title>
            <source>Br J Dermatol</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>136</volume>
            <issue>4</issue>
            <fpage>560</fpage>
            <page-range>560-4</page-range>
            <pub-id pub-id-type="pmid">9155958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lestringant</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Paperna</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bergman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gershoni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Frossard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kanaan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meneguzzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pfendner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pulkkinen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sprecher</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>510</fpage>
            <page-range>510-6</page-range>
            <pub-id pub-id-type="pmid">11907499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morley</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Dundas</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Navsaria</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Leigh</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients.</article-title>
            <source>J Cell Sci</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>108 ( Pt 11)</volume>
            <fpage>3463</fpage>
            <page-range>3463-71</page-range>
            <pub-id pub-id-type="pmid">8586658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r14">
          <label>14</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>So</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Teng</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Epidermolysis Bullosa Simplex</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1998</year>
            <month>10</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">20301543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Suchindran</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-11</page-range>
            <pub-id pub-id-type="pmid">19026465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiritsi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Laminin 332 in junctional epidermolysis bullosa.</article-title>
            <source>Cell Adh Migr</source>
            <year>2013</year>
            <season>Jan-Feb</season>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>135</fpage>
            <page-range>135-41</page-range>
            <pub-id pub-id-type="pmid">23076207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kern</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Collagen XVII.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-6</page-range>
            <pub-id pub-id-type="pmid">19945617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mariath</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Santin</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Frantz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Doriqui</surname>
                <given-names>MJR</given-names>
              </name>
              <name>
                <surname>Schuler-Faccini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kiszewski</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Genotype-phenotype correlations on epidermolysis bullosa with congenital absence of skin: A comprehensive review.</article-title>
            <source>Clin Genet</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-41</page-range>
            <pub-id pub-id-type="pmid">32506467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Recently Identified Forms of Epidermolysis Bullosa.</article-title>
            <source>Ann Dermatol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>658</fpage>
            <page-range>658-66</page-range>
            <pub-id pub-id-type="pmid">26719633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mallipeddi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mayou</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Eady</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>521</fpage>
            <page-range>521-6</page-range>
            <pub-id pub-id-type="pmid">15324385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirkham</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strafford</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Shore</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Bonass</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Brookes</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>The chemical composition of tooth enamel in junctional epidermolysis bullosa.</article-title>
            <source>Arch Oral Biol</source>
            <year>2000</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>377</fpage>
            <page-range>377-86</page-range>
            <pub-id pub-id-type="pmid">10739859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-105</page-range>
            <pub-id pub-id-type="pmid">19945621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baardman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bremer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Diercks</surname>
                <given-names>GFH</given-names>
              </name>
              <name>
                <surname>Jan</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Lemmink</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Bolling</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Van den Akker</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Single glycine deletion in COL7A1 acting as glycine substitution in dystrophic epidermolysis bullosa.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>9</issue>
            <fpage>e597</fpage>
            <page-range>e597-e600</page-range>
            <pub-id pub-id-type="pmid">33914976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Pfendner</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <chapter-title>Dystrophic Epidermolysis Bullosa</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2006</year>
            <month>8</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">20301481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Breitenbach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gruber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Klausegger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trost</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bogner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Reitsamer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Pseudosyndactyly - an inflammatory and fibrotic wound healing disorder in recessive dystrophic epidermolysis bullosa.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>1257</fpage>
            <page-range>1257-66</page-range>
            <pub-id pub-id-type="pmid">26612796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gorell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gillon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rudin</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2021</year>
            <month>Apr</month>
            <day>13</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <pub-id pub-id-type="pmid">33849616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>W&#x000f6;lfle</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Esser</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Brummer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schempp</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>UV-B-induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome.</article-title>
            <source>Hum Mol Genet</source>
            <year>2016</year>
            <month>Dec</month>
            <day>15</day>
            <volume>25</volume>
            <issue>24</issue>
            <fpage>5339</fpage>
            <page-range>5339-5352</page-range>
            <pub-id pub-id-type="pmid">27798104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerrero-Aspizua</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Escamez</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Castiglia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zambruno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Youssefian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vahidnezhad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Requena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Itin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tadini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yordanova</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Del Rio</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2019</year>
            <month>Jul</month>
            <day>24</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>183</fpage>
            <pub-id pub-id-type="pmid">31340837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hon</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>AKC</given-names>
              </name>
            </person-group>
            <article-title>Epidermolysis Bullosa: Pediatric Perspectives.</article-title>
            <source>Curr Pediatr Rev</source>
            <year>2022</year>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>182</fpage>
            <page-range>182-190</page-range>
            <pub-id pub-id-type="pmid">34036913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horn</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Tidman</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>The clinical spectrum of dystrophic epidermolysis bullosa.</article-title>
            <source>Br J Dermatol</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>146</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-74</page-range>
            <pub-id pub-id-type="pmid">11903238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mariath</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Santin</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Schuler-Faccini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kiszewski</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Inherited epidermolysis bullosa: update on the clinical and genetic aspects.</article-title>
            <source>An Bras Dermatol</source>
            <year>2020</year>
            <season>Sep-Oct</season>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>551</fpage>
            <page-range>551-569</page-range>
            <pub-id pub-id-type="pmid">32732072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pulkkinen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity.</article-title>
            <source>Mol Med Today</source>
            <year>1997</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>10</issue>
            <fpage>457</fpage>
            <page-range>457-65</page-range>
            <pub-id pub-id-type="pmid">9358473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Intong</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>How to take skin biopsies for epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-200, vii</page-range>
            <pub-id pub-id-type="pmid">20447481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eady</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Dopping-Hepenstal</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Transmission electron microscopy for the diagnosis of epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>211</fpage>
            <page-range>211-22, vii</page-range>
            <pub-id pub-id-type="pmid">20447483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shetty</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Utility of Immunofluorescence Antigen Mapping in Hereditary Epidermolysis Bullosa.</article-title>
            <source>Indian J Dermatol</source>
            <year>2021</year>
            <season>Jul-Aug</season>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>360</fpage>
            <page-range>360-365</page-range>
            <pub-id pub-id-type="pmid">34759393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tenedini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Artuso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bernardis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Artusi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Percesepe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Rosa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Contin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Manfredini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pellacani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giannetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pagani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tagliafico</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa.</article-title>
            <source>Br J Dermatol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>173</volume>
            <issue>3</issue>
            <fpage>731</fpage>
            <page-range>731-8</page-range>
            <pub-id pub-id-type="pmid">25913354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vahidnezhad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Youssefian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saeidian</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Touati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sotoudeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abiri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barzegar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aghazadeh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mahmoudi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Norouz-Zadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hamid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zahabiyon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bagherian</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zeinali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fortina</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Multigene Next-Generation Sequencing Panel Identifies Pathogenic Variants in Patients with Unknown Subtype of Epidermolysis Bullosa: Subclassification with Prognostic Implications.</article-title>
            <source>J Invest Dermatol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>137</volume>
            <issue>12</issue>
            <fpage>2649</fpage>
            <page-range>2649-2652</page-range>
            <pub-id pub-id-type="pmid">28830826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chamcheu</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Navsaria</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pihl-Lundin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Liovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vahlquist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>T&#x000f6;rm&#x000e4;</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Chemical chaperones protect epidermolysis bullosa simplex keratinocytes from heat stress-induced keratin aggregation: involvement of heat shock proteins and MAP kinases.</article-title>
            <source>J Invest Dermatol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>131</volume>
            <issue>8</issue>
            <fpage>1684</fpage>
            <page-range>1684-91</page-range>
            <pub-id pub-id-type="pmid">21490615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denyer</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Wound management for children with epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>257</fpage>
            <page-range>257-64, viii-ix</page-range>
            <pub-id pub-id-type="pmid">20447488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Infection and colonization in epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-9, ix</page-range>
            <pub-id pub-id-type="pmid">20447490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Margulies</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marion</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saikaly</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Use of Potent Topical Corticosteroids (TCS) for Hypergranulation Tissue (HGT) in Pediatric Patients.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>e28304</fpage>
            <pub-id pub-id-type="pmid">36158443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonamonte</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Filoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Marco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lospalluti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nacchiero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ronghi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Colagrande</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giudice</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cazzato</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.</article-title>
            <source>Cells</source>
            <year>2022</year>
            <month>Apr</month>
            <day>17</day>
            <volume>11</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">35456044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldschneider</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Pain management in epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>273</fpage>
            <page-range>273-82, ix</page-range>
            <pub-id pub-id-type="pmid">20447492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von Bischhoffshausen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ivulic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schuffeneger</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Idiaquez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fuentes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morande</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fuentes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Palisson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>DLH</given-names>
              </name>
              <name>
                <surname>Calvo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Recessive dystrophic epidermolysis bullosa results in painful small fibre neuropathy.</article-title>
            <source>Brain</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>140</volume>
            <issue>5</issue>
            <fpage>1238</fpage>
            <page-range>1238-1251</page-range>
            <pub-id pub-id-type="pmid">28369282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guide</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ba&#x0011f;c&#x00131;</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Feeney</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Steimer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sridhar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Quesada Sanchez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Van Ligten</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parry</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Chitra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kammerman</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.</article-title>
            <source>N Engl J Med</source>
            <year>2022</year>
            <month>Dec</month>
            <day>15</day>
            <volume>387</volume>
            <issue>24</issue>
            <fpage>2211</fpage>
            <page-range>2211-2219</page-range>
            <pub-id pub-id-type="pmid">36516090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haft</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Sprague</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Cotton</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Thyssen</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Eichenfield</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey.</article-title>
            <source>Paediatr Drugs</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>459</fpage>
            <page-range>459-466</page-range>
            <pub-id pub-id-type="pmid">37225932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Resnick</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Porphyria in childhood.</article-title>
            <source>Semin Dermatol</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-9</page-range>
            <pub-id pub-id-type="pmid">7742238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammers</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.</article-title>
            <source>Annu Rev Pathol</source>
            <year>2016</year>
            <month>May</month>
            <day>23</day>
            <volume>11</volume>
            <fpage>175</fpage>
            <page-range>175-97</page-range>
            <pub-id pub-id-type="pmid">26907530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r49">
          <label>49</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Odonwodo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vashisht</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Bullous Systemic Lupus Erythematosus</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">32491377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xie</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Bullous Tinea Pedis.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>97</volume>
            <issue>7</issue>
            <fpage>1396</fpage>
            <page-range>1396-1397</page-range>
            <pub-id pub-id-type="pmid">35787867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seebode</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hennies</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Giehl</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Emmert</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Palmoplantar keratoderma (PPK): acquired and genetic causes of a not so rare disease.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>9</issue>
            <fpage>781</fpage>
            <page-range>781-8</page-range>
            <pub-id pub-id-type="pmid">25176457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Epidermolysis bullosa acquisita.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>1204</fpage>
            <page-range>1204-13</page-range>
            <pub-id pub-id-type="pmid">23368767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taj</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Sajjan</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Ehlers-Danlos syndrome.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>5</volume>
            <issue>Suppl 1</issue>
            <fpage>S68</fpage>
            <page-range>S68-70</page-range>
            <pub-id pub-id-type="pmid">25506578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cammarata-Scalisi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fusco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ursini</surname>
                <given-names>MV</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia Pigmenti.</article-title>
            <source>Actas Dermosifiliogr (Engl Ed)</source>
            <year>2019</year>
            <month>May</month>
            <volume>110</volume>
            <issue>4</issue>
            <fpage>273</fpage>
            <page-range>273-278</page-range>
            <pub-id pub-id-type="pmid">30660327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>South</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020.</article-title>
            <source>Mol Diagn Ther</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-309</page-range>
            <pub-id pub-id-type="pmid">32328988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Gene Therapy for Epidermolysis Bullosa.</article-title>
            <source>J Invest Dermatol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>139</volume>
            <issue>6</issue>
            <fpage>1221</fpage>
            <page-range>1221-1226</page-range>
            <pub-id pub-id-type="pmid">31068252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiritsi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brander</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jose Esc&#x000e1;mez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kohlhase</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van den Akker</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Del Rio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pasmooij</surname>
                <given-names>AMG</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.</article-title>
            <source>J Invest Dermatol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>134</volume>
            <issue>8</issue>
            <fpage>2097</fpage>
            <page-range>2097-2104</page-range>
            <pub-id pub-id-type="pmid">24577406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonafont</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Menc&#x000ed;a</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carretero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chac&#x000f3;n-Solano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Modamio-H&#x000f8;ybj&#x000f8;r</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marinas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Le&#x000f3;n</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Escamez</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Hausser</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Del R&#x000ed;o</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murillas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Larcher</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing.</article-title>
            <source>Mol Ther</source>
            <year>2019</year>
            <month>May</month>
            <day>08</day>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>986</fpage>
            <page-range>986-998</page-range>
            <pub-id pub-id-type="pmid">30930113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shinkuma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Christiano</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2016</year>
            <month>May</month>
            <day>17</day>
            <volume>113</volume>
            <issue>20</issue>
            <fpage>5676</fpage>
            <page-range>5676-81</page-range>
            <pub-id pub-id-type="pmid">27143720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cogan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Antaya</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lincoln</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Woodley</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.</article-title>
            <source>Mol Ther</source>
            <year>2020</year>
            <month>May</month>
            <day>06</day>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>1327</fpage>
            <page-range>1327-1338</page-range>
            <pub-id pub-id-type="pmid">32222156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahajan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Manjunath</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Madakshira</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>De</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Handa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Radotra</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Topical Gentamicin 0.1% Promotes Collagen 7 Expression in Recessive Dystrophic Epidermolysis Bullosa.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2022</year>
            <season>Jul-Aug</season>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>480</fpage>
            <page-range>480-483</page-range>
            <pub-id pub-id-type="pmid">36262564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pourani</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Vahidnezhad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mansouri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Youssefian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rakhshan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hajimoradi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Abdollahimajd</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Losartan treatment improves recessive dystrophic epidermolysis bullosa: A case series.</article-title>
            <source>Dermatol Ther</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>7</issue>
            <fpage>e15515</fpage>
            <pub-id pub-id-type="pmid">35420725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afra</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Razmi</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Dogra</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Apremilast in Psoriasis and Beyond: Big Hopes on a Small Molecule.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2019</year>
            <season>Jan-Feb</season>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">30775293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwieger-Briel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ott</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kiritsi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Laszczyk-Lauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bodemer</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa.</article-title>
            <source>Dermatol Ther</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>e12983</fpage>
            <pub-id pub-id-type="pmid">31168940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kern</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sprecher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Schauer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bodemer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>L&#x000f6;we</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sumeray</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bruckner</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <collab>EASE investigators</collab>
            </person-group>
            <article-title>Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.</article-title>
            <source>Br J Dermatol</source>
            <year>2023</year>
            <month>Jan</month>
            <day>23</day>
            <volume>188</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-21</page-range>
            <pub-id pub-id-type="pmid">36689495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodley</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Keene</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Atha</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lipman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.</article-title>
            <source>Nat Med</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>693</fpage>
            <page-range>693-5</page-range>
            <pub-id pub-id-type="pmid">15195089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aikawa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kikuchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kaneda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tamai</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFR&#x003b1;(+) mesenchymal cells from bone marrow.</article-title>
            <source>Sci Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <day>05</day>
            <volume>5</volume>
            <fpage>11008</fpage>
            <pub-id pub-id-type="pmid">26046579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Intong</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Melbourne</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Marucci</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bucci</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mallesara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.</article-title>
            <source>Br J Dermatol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>169</volume>
            <issue>1</issue>
            <fpage>208</fpage>
            <page-range>208-10</page-range>
            <pub-id pub-id-type="pmid">23398414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atanasova</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Pourreyron</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Farshchian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lawler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Watt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Warkala</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guttmann-Gruber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hofbauer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fuentes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Prisco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rashidghamat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Salas-Alanis</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Palisson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hovnanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>South</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.</article-title>
            <source>Clin Cancer Res</source>
            <year>2019</year>
            <month>Jun</month>
            <day>01</day>
            <volume>25</volume>
            <issue>11</issue>
            <fpage>3384</fpage>
            <page-range>3384-3391</page-range>
            <pub-id pub-id-type="pmid">30846478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunjan</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Bardhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zuzarte</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Balacco</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Heagerty</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2023</year>
            <month>Jun</month>
            <day>05</day>
            <volume>48</volume>
            <issue>6</issue>
            <fpage>706</fpage>
            <page-range>706-707</page-range>
            <pub-id pub-id-type="pmid">36972307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Whalen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rowe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marathe</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Gorell</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Care of the Newborn with Epidermolysis Bullosa.</article-title>
            <source>Neoreviews</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>7</issue>
            <fpage>e438</fpage>
            <page-range>e438-e451</page-range>
            <pub-id pub-id-type="pmid">34210808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kroshinksy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Neonatal junctional epidermolysis bullosa: treatment conundrums and ethical decision making.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>445</fpage>
            <page-range>445-50</page-range>
            <pub-id pub-id-type="pmid">25117154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robertson</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Orrin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lakhan</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Felton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Greenblatt</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Bernardis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2021</year>
            <month>Aug</month>
            <day>24</day>
            <volume>101</volume>
            <issue>8</issue>
            <fpage>adv00523</fpage>
            <pub-id pub-id-type="pmid">34230977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Oral manifestations in the epidermolysis bullosa spectrum.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>159</fpage>
            <page-range>159-64</page-range>
            <pub-id pub-id-type="pmid">19945630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polizzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santonocito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Quinzi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mummolo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leonardi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Isola</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Oral Alterations in Heritable Epidermolysis Bullosa: A Clinical Study and Literature Review.</article-title>
            <source>Biomed Res Int</source>
            <year>2022</year>
            <volume>2022</volume>
            <fpage>6493156</fpage>
            <pub-id pub-id-type="pmid">35686231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fantauzzi</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Cunha</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Sim&#x000f5;es</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>DU</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Otorhinolaryngological and esophageal manifestations of epidermolysis bullosa.</article-title>
            <source>Braz J Otorhinolaryngol</source>
            <year>2008</year>
            <season>Sep-Oct</season>
            <volume>74</volume>
            <issue>5</issue>
            <fpage>657</fpage>
            <page-range>657-661</page-range>
            <pub-id pub-id-type="pmid">19082345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r77">
          <label>77</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Gorell</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <chapter-title>Epidermolysis Bullosa with Pyloric Atresia</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2008</year>
            <month>2</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">20301336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tadini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rossetti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grassi</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Marchisio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Agostoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Giavoli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodari</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guez</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management.</article-title>
            <source>Clin Nutr</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>343</fpage>
            <page-range>343-352</page-range>
            <pub-id pub-id-type="pmid">30857908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reimer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schwieger-Briel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kiritsi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schauer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schumann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bruckner-Tuderman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study.</article-title>
            <source>Br J Dermatol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>182</volume>
            <issue>6</issue>
            <fpage>1437</fpage>
            <page-range>1437-1448</page-range>
            <pub-id pub-id-type="pmid">31487386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freeman</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>K&#x000f6;glmeier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Haynes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sebire</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Lindley</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Gastrointestinal complications of epidermolysis bullosa in children.</article-title>
            <source>Br J Dermatol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>158</volume>
            <issue>6</issue>
            <fpage>1308</fpage>
            <page-range>1308-14</page-range>
            <pub-id pub-id-type="pmid">18363753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Osteopenia and osteoporosis in epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>353</fpage>
            <page-range>353-5, xi</page-range>
            <pub-id pub-id-type="pmid">20447502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vozdvizhensky</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Albanova</surname>
                <given-names>VI</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment of contracture and syndactyly of children with epidermolysis bullosa.</article-title>
            <source>Br J Plast Surg</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>314</fpage>
            <page-range>314-6</page-range>
            <pub-id pub-id-type="pmid">8392421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Faitli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Fawkes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Iacobaccio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vlahovic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brains</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fitzpatrick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mayre-Chilton</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Foot care in epidermolysis bullosa: evidence-based guideline.</article-title>
            <source>Br J Dermatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>182</volume>
            <issue>3</issue>
            <fpage>593</fpage>
            <page-range>593-604</page-range>
            <pub-id pub-id-type="pmid">31397882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alvarez</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Penttil&#x000e4;</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Salutto</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Udd</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mazia</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Epidermolysis bullosa simplex with muscular dystrophy associated with <italic>PLEC</italic> deletion mutation.</article-title>
            <source>Neurol Genet</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>2</volume>
            <issue>6</issue>
            <fpage>e109</fpage>
            <pub-id pub-id-type="pmid">27766310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Figueira</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Coroneo</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic involvement in inherited epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <page-range>143-52</page-range>
            <pub-id pub-id-type="pmid">19945628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cash</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Deleoz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Devries</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Suchindran</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>254</fpage>
            <page-range>254-62</page-range>
            <pub-id pub-id-type="pmid">15289135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cicek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Asadov</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yucelten</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Tugtepe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alpay</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Kidney and Urinary Tract Involvement in Epidermolysis Bullosa: Is Routine Follow-Up Necessary?</article-title>
            <source>Dermatol Pract Concept</source>
            <year>2021</year>
            <month>May</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>e2021051</fpage>
            <pub-id pub-id-type="pmid">34123558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinkampf</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Reilly</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Vaginal agglutination and hematometra associated with epidermolysis bullosa.</article-title>
            <source>Obstet Gynecol</source>
            <year>1987</year>
            <month>Mar</month>
            <volume>69</volume>
            <issue>3 Pt 2</issue>
            <fpage>519</fpage>
            <page-range>519-21</page-range>
            <pub-id pub-id-type="pmid">3808539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma&#x00142;ecki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doma&#x00144;ski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciechanowski</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>End-stage kidney disease in patient with epidermolysis bullosa - what are the treatment options? - case report.</article-title>
            <source>BMC Nephrol</source>
            <year>2017</year>
            <month>Jun</month>
            <day>14</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>193</fpage>
            <pub-id pub-id-type="pmid">28615054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Suchindran</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The risk of cardiomyopathy in inherited epidermolysis bullosa.</article-title>
            <source>Br J Dermatol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>159</volume>
            <issue>3</issue>
            <fpage>677</fpage>
            <page-range>677-82</page-range>
            <pub-id pub-id-type="pmid">18616785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Balasubramanian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Humphreys</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Waruiru</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brauner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kohlhase</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Reilly</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Has</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Intronic ITGA3 Mutation Impacts Splicing Regulation and Causes Interstitial Lung Disease, Nephrotic Syndrome, and Epidermolysis Bullosa.</article-title>
            <source>J Invest Dermatol</source>
            <year>2016</year>
            <month>May</month>
            <volume>136</volume>
            <issue>5</issue>
            <fpage>1056</fpage>
            <page-range>1056-1059</page-range>
            <pub-id pub-id-type="pmid">26854491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyos</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Malpica</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sulek</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Laryngeal involvement in epidermolysis bullosa.</article-title>
            <source>Ann Otol Rhinol Laryngol</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>103</volume>
            <issue>7</issue>
            <fpage>542</fpage>
            <page-range>542-6</page-range>
            <pub-id pub-id-type="pmid">8024217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Mellerio</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>The psychological functioning of children with epidermolysis bullosa and its relationship with specific aspects of disease.</article-title>
            <source>Br J Dermatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>182</volume>
            <issue>3</issue>
            <fpage>789</fpage>
            <page-range>789-790</page-range>
            <pub-id pub-id-type="pmid">31587254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruckner</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Losow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wisk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Reha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lagast</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gault</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gershkowitz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kopelan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hund</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2020</year>
            <month>Jan</month>
            <day>03</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">31900176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfendner</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Nakano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pulkkinen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Christiano</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prenatal diagnosis for epidermolysis bullosa: a study of 144 consecutive pregnancies at risk.</article-title>
            <source>Prenat Diagn</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>447</fpage>
            <page-range>447-56</page-range>
            <pub-id pub-id-type="pmid">12813757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sybert</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Genetic counseling in epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>239</fpage>
            <page-range>239-43, viii</page-range>
            <pub-id pub-id-type="pmid">20447486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fassihi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Prenatal diagnosis of epidermolysis bullosa.</article-title>
            <source>Dermatol Clin</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>231</fpage>
            <page-range>231-7, viii</page-range>
            <pub-id pub-id-type="pmid">20447485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fassihi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Renwick</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Braude</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Development and successful clinical application of preimplantation genetic haplotyping for Herlitz junctional epidermolysis bullosa.</article-title>
            <source>Br J Dermatol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>162</volume>
            <issue>6</issue>
            <fpage>1330</fpage>
            <page-range>1330-6</page-range>
            <pub-id pub-id-type="pmid">20163412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Amber</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>557</fpage>
            <page-range>557-565</page-range>
            <pub-id pub-id-type="pmid">32180161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-158627.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Retrosi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Diociaiuti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Ranieri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Corbeddu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carnevale</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Giancristoforo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marchili</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Salvatori</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Atti</surname>
                <given-names>MLCD</given-names>
              </name>
              <name>
                <surname>El Hachem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raponi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center.</article-title>
            <source>Ital J Pediatr</source>
            <year>2022</year>
            <month>Apr</month>
            <day>12</day>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <pub-id pub-id-type="pmid">35414096</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
